Journal Browser

Journal Browser

Special Issue "Shaping Medicinal Chemistry for the New Decade"

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: 31 December 2022 | Viewed by 243

Special Issue Editors

Dr. Diego Muñoz-Torrero
E-Mail Website1 Website2
Guest Editor
Laboratory of Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Interests: multitarget anti-Alzheimer agents; hybrid compounds; cholinesterase inhibitors; amyloid anti-aggregating compounds; BACE-1 inhibitors; antiprotozoan compounds
Special Issues, Collections and Topics in MDPI journals
Dr. Rino Ragno
E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

Medicinal chemistry must be continuously shaped to confront changing therapeutic challenges, to adapt to emerging novel drug modalities, and to take advantage of new technologies with high potential to speed up drug discovery.

This Special Issue is related to the Third Molecules Medicinal Chemistry Symposium—Shaping Medicinal Chemistry for the New Decade (MMCS2022), which will be held in Rome (Italy) on July 27–29, 2022. At the Symposium, current challenges in the drug discovery field will be discussed while reporting novel and revisited drug discovery approaches against particularly challenging diseases, and medicinal chemistry stories about recently implemented projects in target and hit identification, hit-to-lead optimization, tuning of physicochemical and pharmacokinetic properties, preclinical and clinical development, etc.

Participants of the Symposium and all researchers working in the field are cordially invited to contribute original research articles, short communications, or reviews to this Special Issue of Molecules, reporting on recent innovative medicinal-chemistry projects, particularly (but not exclusively) regarding the design and development of novel drug candidates against drug-resistant microorganisms and SARS-CoV-2, different modalities of targeting protein degradation with therapeutic purposes, the use of machine learning in drug design, the use of natural products in drug discovery, and the rational design and profiling of multitarget agents to tackle multifactorial diseases. Participants of this conference are encouraged to contribute with a full manuscript to our Special Issue related to the conference in the journal Molecules. The conference participants will be granted a 30% discount on the publishing fees. For planned manuscripts, a title and short abstract (about 100 words) should be sent to the Editorial Office for announcement on this website.

Dr. Diego Muñoz-Torrero
Dr. Rino Ragno
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • drug discovery
  • drug design
  • drug synthesis
  • SARS-CoV-2
  • anti-infective agents
  • targeted protein degraders
  • multitarget drugs
  • machine learning
  • natural products
  • novel drugs

Published Papers

This special issue is now open for submission.
Back to TopTop